Back
Biogen, Inc. 10K Form
Sell
50
BIIB
Biogen, Inc.
Last Price:
$174.84
Seasonality Move:
8.72%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BIIB News And Ratings
See the #1 stock for the next 7 days that we like better than BIIB
BIIB Financial Statistics
Sales & Book Value
| Annual Sales: | $9.3B |
|---|---|
| Cash Flow: | $1.2B |
| Price / Cash Flow: | 11.32 |
| Annual Sales: | $124.11 |
| Price / Book: | 1.41 |
Profitability
| EPS (TTM): | 10.96520 |
|---|---|
| Net Income (TTM): | $1.6B |
| Gross Margin: | $6.3B |
| Return on Equity: | 9.36% |
| Return on Assets: | 5.67% |
Biogen, Inc. Earnings Forecast
Key Biogen, Inc. Financial Ratios
-
The Gross Profit Margin over the past 41 years for BIIB is 67.80%.
-
The Selling, General & Administrative Expenses for BIIB have been equal to 25.94% of Gross Profit Margin.
-
The Research & Development expenses have been 18.94% of Revenue.
-
The Interest Expense is 15.34% of Operating Income.
-
The Net Earning history of BIIB is 17.61% of Total Revenues.
-
Per Share Earnings over the last 41 years have been positive in 25 years.
Biogen, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BIIB |
| CUSIP: | 09062X |
| Website: | biogen.com |
Debt
| Debt-to-Equity Ratio: | 0.36 |
|---|---|
| Current Ratio: | 2.72 |
| Quick Ratio: | 1.77 |
Price-to-Earnings
| Trailing P/E Ratio: | 15.62 |
|---|---|
| Forward P/E Ratio: | 11.47 |
BIIB Technical Analysis vs Fundamental Analysis
Sell
50
Biogen, Inc. (BIIB)
is a Sell
Is Biogen, Inc. a Buy or a Sell?
-
Biogen, Inc. stock is rated a SellThe current Biogen, Inc. [BIIB] share price is $174.70. The Score for BIIB is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.